Average Co-Inventor Count = 4.97
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Voyager Therapeutics, Inc. (6 from 41 patents)
2. Arrowhead Pharmaceuticals, Inc. (4 from 96 patents)
3. Aligos Therapeutics, Inc. (3 from 34 patents)
4. Mina Therapeutics Limited (3 from 16 patents)
5. Neurovision Pharma Gmbh (2 from 2 patents)
6. Arrowhead Madison, Inc. (1 from 19 patents)
7. Arrowhead Research Corporation (1 from 18 patents)
20 patents:
1. 12454691 - Modified short interfering nucleic acid (siNA) molecules and uses thereof
2. 12129469 - Modified short interfering nucleic acid (siNA) molecules and uses thereof
3. 12123002 - Compositions and methods of treating amyotrophic lateral sclerosis (ALS)
4. 11965163 - HNF4a saRNA compositions and methods of use
5. 11951121 - Compositions and methods for treating Huntington's disease
6. 11920134 - Compositions and methods for inhibiting expression of RRM2 genes
7. 11752181 - Compositions and methods of treating Huntington's disease
8. 11549110 - Modified short interfering nucleic acid (siNA) molecules and uses thereof
9. 11542506 - Compositions and methods of treating amyotrophic lateral sclerosis (ALS)
10. 11213541 - Antisense-oligonucleotides as inhibitors of TGF-R signaling
11. 11162099 - HNF4A saRNA compositions and methods of use
12. 10920227 - Compositions and methods of treating amyotrophic lateral sclerosis (ALS)
13. 10912790 - C/EBP alpha saRNA compositions and methods of use
14. RE48345 - Compositions and methods for inhibiting gene expression of hepatitis B virus
15. 10619160 - Compositions and methods for inhibiting expression of RRM2 genes